Schneider Institute for Health Policy, The Heller School for Social Policy and Management, Brandeis University Thoughts on Research Design Donald Shepard.

Slides:

Advertisements

Similar presentations

The need to challenge unhealthy drug policies to improve drug treatment Dr Chris Ford, Holly Catania and Rebecca Murchie IDHDP.

Advertisements

HIV and Harm Reduction Winning on policy front : Faltering on Implementation JVR Prasada Rao, UNAIDS XVIII International Harm Reduction Conference Warsaw,

Workshop IV: Provision of Health Care The Impact of International Standards and Guidelines on prisoner health in Eastern and Central Europe Antalya, Turkey.

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.

Aligning Policing and Harm Reduction: Research to Practice Leo Beletsky, JD, MPH Northeastern University USA.

Kathleen H. Reilly, MPH 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention Rome, Italy July 18, 2011.

A Review of Barriers and Ways Forward Daniel Wolfe 1 M. Patrizia Carrieri 2 Donald Shepard 3 Paper 3 Treatment and Care for IDUS with HIV 1. Open Society.

Cost-Effectiveness of Needle Exchange Program among IDUs in Uzbekistan Azizbek A. Boltaev IREX Contemporary Issues Program Fellow Dynamic Communications:

European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.

Operational Approaches for Comprehensive Sex Worker Programmes An overview of Implementing Comprehensive HIV/STI Programmes with Sex Workers: Practical.

Welcome, Agenda, Challenges and Potential Solutions Implementing Evidence-Based Practices and Performance Measures for Massachusetts Mental Health Services:

Schneider Institute for Health Policy, The Heller School for Social Policy and Management, Brandeis University Issues in Cost Analysis of Substance Abuse.

Schneider Institute for Health Policy, The Heller School for Social Policy and Management, Brandeis University Tools of Managed Care and their Potential.

1 Presented by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy Heller School, Room 122A, Mail Stop 035 Brandeis University Waltham, MA

Schneider Institute for Health Policy, The Heller School for Social Policy and Management, Brandeis University Project Management Prevention strategies.

Schneider Institute for Health Policy Heller School Brandeis University September by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy.

Schneider Institute for Health Policy Heller Graduate School Brandeis University 1 by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy Heller.

Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network.

Preventive Measures on HIV/AIDS Because the most common ways HIV is transmitted is through anal or viginal sex or sharing drug injection equipment with.

HIV and drug prevention in Estonia Harm reduction services

NACO and NACP. Response of Govt to HIV National AIDS Control Programme (NACP) under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999) NACP.

Louisa Degenhardt 1, Bradley Mathers 1, Peter Vickerman 2, Tim Rhodes 3, Carl Latkin 4 and Matt Hickman 5 1.National Drug and Alcohol Research Centre,

Harm Reduction.

Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.

Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.

A Review of Barriers and Ways Forward Daniel Wolfe 1 Patrizia Carrieri 2 Donald Shepard 3 Paper 3 Treatment and Care for IDUS with HIV 1. Open Society.

Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.

Results from the Spanish experience: A comprehensive approach to HIV and HCV in prisons MERCEDES GALLIZO LLAMAS Secretary-General of Spanish Prison Administration.

Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.

1 Controlling HIV among injecting drug users: current status of harm reduction International AIDS Conference, Toronto, 15 August 2006 Dr. Alex Wodak, Sydney,

HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.

Office of Overseas Programming & Training Support (OPATS) Positive Health, Dignity, and Prevention HIV Prevention.

Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.

Needle Exchange Programs Jessica Sullivan Health Education & Behavior.

David Marash-Whitman 11/20/13. KPC (Klebsiella pneumoniae carbapenemase) 18 infected patients 6 fatalities complete drug resistance persistent presence.

Resource Needs Model Rachel Sanders October 28 th, 2010.

1 Presented by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy Heller School, Room 122A, Mail Stop 035 Brandeis University Waltham, MA

Washington D.C., USA, July 2012www.aids2012.org Alternatives to NSEPs: community-based initiatives Providing access to syringes in the politically.

Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,

ORIENTATION FOR MSM -TARGETED HARM REDUCTION INTERVENTIONS Vietnam Administration For AIDS Control Ministry of Health.

Harm Reduction International

HIV/AIDS, Housing and Risk Behaviors CT AIDS Resource Coalition and CIRA Community Research Partnership Program.

HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.

Global Evidence of Comparative Efficiency: Performance of National HIV/AIDS Programs Donald S. Shepard, PhD Wu Zeng, MD, PhD Jon Chilingerian, PhD Carlos.

Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.

Walking a Thin “Wire”: The Attitudes and Principles of Harm Reduction Niladri Das, MD UPMC St. Margaret Family Medicine Residency Daniel Dejoseph,MD Drexel.

Health Risk Factors in Population Sexually Active Sexually Transmitted Diseases Injecting drugs and other substance abuse Babies born from infected mothers.

Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.

Harm reduction saves the lives of millions: will Eastern Europe take the chance? Andriy Klepikov, Intenational HIV/AIDS Alliance in Ukraine 24 th of June,

1 Barriers to access to sterile syringes in Canada: legal, policy and human rights issues XVI International AIDS conference Tuesday, 15 August 2006 Alana.

Cost-Effectiveness of health programs April 10, 2000

International Harm Reduction Development Program: Lessons learned

MODULE 3 Harm reduction advocacy

Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC

Riga city Council Welfare department HIV prevention

Fabienne Hariga Senior Adviser, HIV/AIDS Section

Eurasian Harm Reduction Network (EHRN)

The Efficacy of RN Supervised Safe Injection Sites

Planning for Evaluation

Addressing Drug Use Together Through a Health Based Approach:

What is Community Housing Network?

Preliminary Draft 5 Year Action Plan HIV, Hepatitis C, and STIs

The HIV Epidemic among People who Inject Drugs

Biomedical Prevention Is Always About Social Justice, Too

ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS

Cost-Effectiveness of health programs April 17, 2000

HA-REACT Joint Action WP4 Testing and Linkage to care Methods:

National HIV notifications Q – Q4 2018

Human Dignity and Harm Reduction

Share your thoughts on this presentation with #IAS2019

Presentation transcript:

Schneider Institute for Health Policy, The Heller School for Social Policy and Management, Brandeis University Thoughts on Research Design Donald Shepard Azizbek Boltaev August 18, 2004

Problem Uzbekistan faces growing HIV infection, primarily related to IV drug use International literature suggests promising approaches: Syringe exchange Condom promotion Substitute treatment

Objectives Identify the barriers to participation in harm reduction programs in Uzbekistan. Test whether an application of program theory, tangible incentives improves the coverage and effectiveness of harm reduction programs.